Quantcast

Latest Prenatal diagnosis Stories

2011-08-15 06:38:37

(Ivanhoe Newswire) -- As a noninvasive method of determining the sex of a fetus, tests using cell-free fetal DNA obtained from the mother's blood after 7 weeks gestation performed well, while urine-based tests appear to be unreliable, according to this study. Noninvasive prenatal determination of fetal sex could provide an important alternative to invasive cytogenetic determination, which is currently the gold standard for determining sex and single-gene disorders. Amniocentesis has small but...

2011-08-11 06:40:02

(Ivanhoe Newswire) -- A quick, non-invasive test that measures blood oxygen levels in newborns detects more cases of life-threatening congenital heart defects than current standard approaches and should be adopted into the routine assessment of all newborns before discharge from hospital, according to this study. Congenital heart defects are one of the leading causes of deaths in infants in the developed world. Current screening techniques involving a mid-trimester ultrasound scan and a...

2011-08-10 11:30:00

SAN DIEGO, Aug. 10, 2011 /PRNewswire/ -- TrovaGene, Inc. (Pink Sheets: TROV.PK), a developer of transrenal molecular diagnostics, confirmed today that it regained ownership of its worldwide rights and control over its patent estate for transrenal technology for non-invasive prenatal applications and cancer through the termination of a license agreement between TrovaGene and Sequenom, Inc. (NASDAQ: SQNM). In 2008, TrovaGene licensed several of its patents to Sequenom for the development of...

2011-08-09 07:00:00

SAN CARLOS, Calif., Aug. 9, 2011 /PRNewswire/ -- Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced that it has raised approximately $46.5 million in the finalization of its Series C financing with the remaining $2.0 million expected to close on August 31, 2011. The funding was led by existing investors Mohr Davidow Ventures, Sutter Hill Ventures, and Alloy Ventures. Verinata plans to use the proceeds to fund continued research and...

2011-08-09 07:00:00

SAN CARLOS, Calif., Aug. 9, 2011 /PRNewswire/ -- Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced the appointment of James D. Goldberg, M.D., to its Clinical Advisory Board. The Clinical Advisory Board helps to guide the development of Verinata's non-invasive prenatal diagnostic test. "Dr. Goldberg is internationally-renowned for his leadership in the area of maternal fetal medicine and prenatal genetic testing," said Caren Mason,...

2011-08-04 15:15:00

SAN DIEGO, Aug. 4, 2011 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today reported revenue of $13.3 million for the second quarter of 2011, an increase of 17% compared to revenue of $11.4 million for the second quarter of 2010. Net loss for the second quarter of 2011 was $20.9 million or $0.21 per share, as compared to net loss of $59.1 million, or $0.86 per share for the same period in 2010. Gross margin for the...

2011-06-27 00:00:29

Over 200 children treated before they were born by CHOP's Center for Fetal Diagnosis and Treatment, and their families, gathered to celebrate 15 years of Hope. The reunion brings together a unique community of families who have shared similar struggles. Nearly all of the children in attendance were prenatally diagnosed with a birth defect that had potentially devastating outcomes. Babies diagnosed with these birth defects either underwent fetal surgery to treat the condition before birth or...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related